Pharmaceutical research and drug production in Nigeria has received a boost with a $400,000 grant funding by African Export-Import Bank, Afrexim Bank.
The gesture to the National Institute for Pharmaceutical Research and Development, NIPRD, in Jos will assist Nigeria to establish an Active Pharmaceutical Ingredient, API, plant. The bank is providing part of the funds required to implement the project.
Presently, pharmaceutical manufacturing companies in Africa rely heavily on the importation of APIs and excipients which are essential to formulate finished pharmaceutical products. The Afrexim Bank grant will enable NIPRD to produce APIs locally in Nigeria. NIPRD’s API plant project is a critical step towards Nigeria’s pharmaceutical independence and self-sufficiency.
In addition, the project includes the development of a contextual training programme for pharmaceutical industry stakeholders, to ensure that key skills are acquired by industry players who represent the vanguard of essential medicines production on the continent.
Afrexim Bank’s financial support to the NIPRD APIs plant project will not only catalyse the security of supply of medicines across Africa but also promote the industrialisation of the pharmaceutical sector and the consequent creation of jobs and income.
This landmark partnership between NIPRD and Afrexim Bank opens a new perspective in the development of collaborative projects aimed at providing contextual solutions to issues that emerge on the continent. This collaboration demonstrates a paradigm shift towards a new approach to improving sustainable access to healthcare in Africa, while stimulating socioeconomic development.
NIPRD was established in 1987 to enhance the development and commercialization of pharmaceutical raw materials, drugs and biological products from Nigeria’s indigenous natural resources. It is also mandated to engage in activities relating to capacity building, policy making, data collation, drug distribution and the development of contextual partnership that can expedite access to healthcare.
In achieving these objectives, a significant number of relevant international accreditations and certifications have been attained by the Institute, including ISO 9001:2008 certified by the Standard Organization of Nigeria and ISO 17025:2015 in the field of technical competence in testing.
The Institute’s work has been globally recognized as evidenced by awards such as its recent designation as Centre of Excellence in the African Sub-region towards improving the health and wellbeing of Nigerians and mankind by the African Network for Drugs and Diagnostics Innovation.
7 total views, 2 views today